EcoDrugPlus

Ribosomal Protein S7

Ensembl ID : ENSODEG00000000219
Gene Symbol: RPS7
3 Cross references
167 Possible Orthologues:

Ribosomal Protein S8

Ensembl ID : ENSODEG00000008551
Gene Symbol: RPS8
2 Cross references
168 Possible Orthologues:

Ribosomal Protein S9

Ensembl ID : ENSODEG00000002087
Gene Symbol: RPS9
3 Cross references
215 Possible Orthologues:

Secretin Receptor

Ensembl ID : ENSODEG00000006551
Gene Symbol: SCTR
1 Cross references
130 Possible Orthologues:

Selectin L

Ensembl ID : ENSODEG00000000030
Gene Symbol: SELL
1 Cross references
86 Possible Orthologues:

Selectin P

Ensembl ID : ENSODEG00000000018
Gene Symbol: SELP
3 Cross references
120 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSODEG00000015160
Gene Symbol: SIGMAR1
3 Cross references
204 Possible Orthologues:

Sirtuin 1

Ensembl ID : ENSODEG00000005951
Gene Symbol: SIRT1
3 Cross references
155 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSODEG00000012811
Gene Symbol: SMO
1 Cross references
204 Possible Orthologues:

Sodium Channel Epithelial 1 Subunit Alpha

Ensembl ID : ENSODEG00000004767
Gene Symbol: SCNN1A
1 Cross references
153 Possible Orthologues:

Sodium Channel Epithelial 1 Subunit Beta

Ensembl ID : ENSODEG00000012017
Gene Symbol: SCNN1B
3 Cross references
151 Possible Orthologues:

Sodium Channel Epithelial 1 Subunit Gamma

Ensembl ID : ENSODEG00000013886
Gene Symbol: SCNN1G
3 Cross references
155 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).